CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






Sodium azide

RTECS #: VY8050000

CAS #: 26628-22-8


UPDATE: May 2009 MW: 65.02 MF: N3Na


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. MUTATION DATA:
  3. TUMORIGENIC DATA:
  4. ACUTE TOXICITY DATA:
  5. OTHER MULTIPLE DOSE DATA:
  6. REVIEWS:
  7. STANDARDS AND REGULATIONS:
  8. NIOSH DOCUMENTATION AND SURVEILLANCE:
  9. STATUS IN FEDERAL AGENCIES:
  10. REFERENCES:

SYNONYMS:

  1. Azide, sodium
  2. Azoture de sodium (French)
  3. Azydek sodu (Polish)
  4. Kazoe
  5. NCI - C06462
  6. NSC 3072
  7. Natriumazid (German)
  8. Natriummazide (Dutch)
  1. Nemazyd
  2. RCRA waste number P105
  3. Smite
  4. Sodium azide (ACGIH)
  5. Sodium, azoture de (French)
  6. Sodium, azoturo di (Italian)
  7. U - 3886


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
dominant lethal test oral
other insects
100 mg/L EXPEAM 37,824,1981
DNA damage human leukocyte 3 mmol/L MUREAV 468,93,2000
DNA damage human mammary gland 5.2 mg/L/24 hour (-enzymatic activation step) MUREAV 588,47,2005
DNA inhibition human HeLa cell 30 mmol/L CRNGDP 13,2389,1992
DNA inhibition human fibroblast 50 mg/L STBIBN 78,165,1980
DNA repair Escherichia coli 5 gm/L MUREAV 119,135,1983
mutation in microorganisms Escherichia coli 150 nmol/L (-enzymatic activation step) ENMUDM 3,11,1981
mutation in microorganisms Escherichia coli 33,300 ng/plate (+enzymatic activation step) ENMUDM 6(Suppl 2),1,1984
mutation in microorganisms Escherichia coli 10 g/well/12 hour MUREAV 520,161,2002
mutation in microorganisms Escherichia coli 5 g/plate/48 hour MUTAEX 15,317,2000
mutation in microorganisms Euglena gracilis 5 mg/L (-enzymatic activation step) TCMUD8 5,329,1985
mutation in microorganisms other microorganisms 600 ppm (-enzymatic activation step) POASAD 34,114,1953
mutation in microorganisms Salmonella typhimurium 30 ng/plate (+enzymatic activation step) ENMUDM 9(Suppl 9),1,1987
mutation in microorganisms Salmonella typhimurium 1.5 g/plate/44 hour FCTOD7 40,105,2002
mutation in microorganisms Salmonella typhimurium 1 g/plate/3 hour (-enzymatic activation step) FCTOD7 40,1,2002
mutation in microorganisms Salmonella typhimurium 1 g/plate/20 minute (-enzymatic activation step) MUREAV 494,41,2001
mutation in microorganisms Salmonella typhimurium 0.5 g/plate/90 minute (-enzymatic activation step) MUREAV 490,45,2001
mutation in microorganisms Salmonella typhimurium 1 g/plate/20 minute (+enzymatic activation step) EMMUEG 37,324,2001
mutation in microorganisms Salmonella typhimurium 1.5 g/plate/24 hour (+/-enzymatic activation step) BECTA6 65,691,2000
mutation in microorganisms Salmonella typhimurium 1.5 L/plate (-enzymatic activation step) VHTODE 42,77,2000
mutation in microorganisms Salmonella typhimurium 10 mg/L/48 hour MUREAV 520,161,2002
mutation in microorganisms Salmonella typhimurium 1.5 g/plate/2 day (+/-enzymatic activation step) BECTA6 65,691,2000
mutation in microorganisms Salmonella typhimurium 20 mg/L/72 hour (-enzymatic activation step) EMMUEG 36,52,2000
mutation in microorganisms Salmonella typhimurium 0.1 mg/plate/3 day MUREAV 521,19,2002
mutation in microorganisms Salmonella typhimurium 0.25 mg/plate/45 minute (-enzymatic activation step) TCMUD8 22,285,2002
mutation in microorganisms Salmonella typhimurium 1.25 g/plate/2 day (-enzymatic activation step) MUREAV 537,201,2003
mutation in microorganisms Salmonella typhimurium mammary gland 5 g/plate/48 hour (-enzymatic activation step) EMMUEG 41,43,2003
mutation in microorganisms Salmonella typhimurium 0.2 mol/plate/72 hour (-enzymatic activation step) MUREAV 558,93,2004
mutation in microorganisms Salmonella typhimurium 1 g/plate/24 hour (-enzymatic activation step) TCMUD8 23,137,2003
mutation in microorganisms Salmonella typhimurium embryo 0.5 g/plate/72 hour (-enzymatic activation step) MUREAV 561,101,2004
mutation in microorganisms Salmonella typhimurium 0.25 mg/plate/48 hour TCMUD8 23(Suppl 1),85,2003
mutation in microorganisms Salmonella typhimurium 0.5 g/plate/72 hour (-enzymatic activation step) MUREAV 585,105,2005
mutation in microorganisms Salmonella typhimurium 0.1 gm/L (+enzymatic activation step) DCTODJ 27,157,2004
mutation in microorganisms Salmonella typhimurium 0.1 gm/L (-enzymatic activation step) DCTODJ 27,157,2004
mutation in microorganisms Salmonella typhimurium 440 nmol/L/48 hour (-enzymatic activation step) ARTODN 77,298,2003
mutation in microorganisms Salmonella typhimurium 160 mg/L/2 hour (-enzymatic activation step) MUREAV 578,210,2005
mutation in microorganisms Salmonella typhimurium 90 mg/L/2 hour (+enzymatic activation step) MUREAV 578,210,2005
mutation in microorganisms Salmonella typhimurium 0.15 mol/plate/73 hour (-enzymatic activation step) MUREAV 629,122,2007
mutation in microorganisms Salmonella typhimurium 1.25 g/plate/30 minute (-enzymatic activation step) CPBTAL 55,1635,2007
mutation in microorganisms Salmonella typhimurium 0.5 g/plate (-enzymatic activation step) FCTOD7 46,1042,2008
mutation in microorganisms Salmonella typhimurium 0.5 g/plate/48 hour (-enzymatic activation step) FCTOD7 46,2190,2008
mutation in microorganisms Saccharomyes cerevisiae 0.66 mg/L/16 hour MUTAEX 20,105,2004
mutation in microorganisms Saccharomyes cerevisiae 2.5 mg/L/18 hour (+/-enzymatic activation step) MUREAV 653,63,2008
mutation in mammalian somatic cells hamster lung 1 mmol/L MUREAV 77,293,1980
mutation in mammalian somatic cells mouse lymphocyte 500 mg/L/2 hour MUREAV 59,61,1979
mutation in mammalian somatic cells rat liver 1 mmol/L MUREAV 77,293,1980
phage inhibition capacity Escherichia coli 1,100 ng/well MUREAV 260,349,1991
specific locus test oral
Drosophila melanogaster
500 mol/L MUREAV 389,157,1997
heritable translocation test oral
other insects
100 mg/L EXPEAM 37,824,1981


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
oral
rat
lowest published toxic dose: 2,730 mg/kg/78 week- continuous Tumorigenic: Equivocal tumorigenic agent by RTECS criteria

Endocrine: Tumors

Skin and Appendages: Tumors
JJIND8 67,75,1981
oral
rat
toxic dose : 5,460 mg/kg/78 week- continuous Tumorigenic: Equivocal tumorigenic agent by RTECS criteria

Endocrine: Tumors

Skin and Appendages: Tumors
JJIND8 67,75,1981


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
inhalation
mouse
lethal concentration (50 percent kill): 32,400 g/m3 Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi
STGNBT -,173,1999
inhalation
rat
lethal concentration (50 percent kill): 37 mg/m3 Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi
STGNBT -,173,1999
intraperitoneal
mouse
lethal dose (50 percent kill): 28 mg/kg Behavioral: Convulsions or effect on seizure threshold

Behavioral: Change in motor activity (specific assay)

Lung, Thorax, or Respiration: Respiratory stimulation
JIHTAB 30,98,1948
intraperitoneal
rat
lowest published lethal dose: 30 mg/kg N/R PHRPA6 58,607,1943
intraperitoneal
rat
lowest published lethal dose: 3 mg/kg Behavioral: Coma

Lung, Thorax, or Respiration: Respiratory depression

Nutritional and Gross Metabolic: Body temperature decrease
VCVN5* -,25,1993
intratracheal
rat
lethal dose (50 percent kill): 47,500 g/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes
MEPAAX 12,427,1961
intratracheal
rat
lethal dose (50 percent kill): 47.5 mg/kg N/R VCVN5* -,26,1993
intravenous
monkey
lowest published lethal dose: 12 mg/kg Eye: Mydriasis (pupilliary dilation)

Behavioral: Convulsions or effect on seizure threshold

Vascular: BP lowering not characterized in autonomic section
BRAIAK 95,505,1972
intravenous
mouse
lethal dose (50 percent kill): 19 mg/kg N/R CLDND*
oral
wild bird
lethal dose (50 percent kill): 23,700 g/kg N/R AECTCV 12,355,1983
oral
human
lowest published toxic dose: 710 g/kg Behavioral: General anesthetic

Behavioral: Somnolence (general depressed activity)

Kidney, Ureter, and Bladder: Other changes
JCPAAK 28,350,1975
oral
man
lowest published lethal dose: 29 mg/kg Brain and Coverings: Increased intracranial pressure

Cardiac: Pulse rate decreased with fall in BP

Lung, Thorax, or Respiration: Acute pulmonary edema
MTAEEB 4,219,1989
oral
man
lowest published lethal dose: 129 mg/kg Behavioral: Coma

Cardiac: Pulse rate decreased with fall in BP

Cardiac: Other changes
JATOD3 20,134,1996
oral
man
lowest published lethal dose: 143 mg/kg Eye: Mydriasis (pupilliary dilation)

Behavioral: Somnolence (general depressed activity)

Behavioral: Irritability
JTCTDW 24,339,1986
oral
man
lowest published toxic dose: 129 g/kg Cardiac: Pulse rate increased without fall in BP

Vascular: BP lowering not characterized in autonomic section

Blood: Changes in spleen
YAKUD5 40,1407,1998
oral
man
lowest published toxic dose: 1,143 g/kg Cardiac: Cardiomyopathy including infarction

Lung, Thorax, or Respiration: Other changes

Musculoskeletal: Other changes
BJIMAG 39,308,1982
oral
mouse
lethal dose (50 percent kill): 27 mg/kg N/R USXXAM #6365129
oral
rat
lethal dose (50 percent kill): 27 mg/kg N/R FMCHA2 -,C32,1991
oral
woman
lowest published lethal dose: 786 mg/kg Behavioral: Convulsions or effect on seizure threshold

Behavioral: Coma

Cardiac: Arrythmias (indlucing changes in conduction)
MTAEEB 4,219,1989
oral
woman
lowest published lethal dose: 14 mg/kg Behavioral: Convulsions or effect on seizure threshold

Cardiac: Arrythmias (indlucing changes in conduction)

Cardiac: Change in force of contraction
JFSCAS 35,193,1990
oral
woman
lowest published toxic dose: 3 mg/kg Behavioral: Headache

Lung, Thorax, or Respiration: Dyspnea

Gastrointestinal: Hypermotility, diarrhea
ATXKA8 20,279,1965
subcutaneous
mouse
lethal dose (50 percent kill): 23,060 g/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes
MEPAAX 12,427,1961
subcutaneous
mouse
lethal dose (50 percent kill): 23 mg/kg N/R VCVN5* -,26,1993
subcutaneous
rat
lethal dose (50 percent kill): 45,100 g/kg Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change

Lung, Thorax, or Respiration: Other changes
MEPAAX 12,427,1961
subcutaneous
rat
lethal dose (50 percent kill): 45 mg/kg N/R VCVN5* -,26,1993
subcutaneous
rabbit
lowest published lethal dose: 17 mg/kg N/R ATXKA8 22,160,1966
skin
rat
lethal dose (50 percent kill): 50 mg/kg N/R STGNBT -,173,1999
skin
rabbit
lethal dose (50 percent kill): 20 mg/kg N/R FMCHA2 -,C32,1991
unreported route
mouse
lethal dose (50 percent kill): 27 mg/kg N/R BJCAAI 6,160,1952


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intraperitoneal
rat
lowest published toxic dose: 15 mg/kg/5 day- intermittent Lung, Thorax, or Respiration: Respiratory depression

Nutritional and Gross Metabolic: Body temperature decrease

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
VCVN5* -,25,1989
oral
mammal (species unspecified)
lowest published toxic dose: 240 mg/kg/30 day- intermittent Cardiac: EKG changes not diagnostic of above

Vascular: BP lowering not characterized in autonomic section

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
STGNBT -,173,1999
oral
mammal (species unspecified)
lowest published toxic dose: 45,500 g/kg/26 week- intermittent Cardiac: EKG changes not diagnostic of above

Liver: Liver function tests impaired

Kidney, Ureter, and Bladder: Other changes in urine composition
STGNBT -,173,1999
oral
mouse
lowest published toxic dose: 81,250 g/kg/13 week- intermittent Liver: Changes in liver weight TOXID9 5,195,1985
oral
rat
lowest published toxic dose: 5,206 mg/kg/39 day- continuous Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
PHRPA6 58,607,1943
oral
rat
lowest published toxic dose: 81,250 g/kg/13 week- intermittent Liver: Changes in liver weight NTPTR* NTP-TR-389,1991
oral
rat
lowest published toxic dose: 240 mg/kg/14 day- intermittent Cardiac: Changes in heart weight

Liver: Changes in liver weight

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* NTP-TR-389,1991
oral
rat
lowest published toxic dose: 5,150 mg/kg/103 week- intermittent Blood: Leukemia

Endocrine: Adrenal cortex tumors

Tumorigenic: Active as anti-cancer agent
NTIS** PB92-135615
oral
rat
lowest published toxic dose: 2,575 mg/kg/103 week- intermittent Skin and Appendages: Tumors

Tumorigenic: Active as anti-cancer agent
NTIS** PB92-135615
subcutaneous
rat
lowest published toxic dose: 740 mg/kg/74 day- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field MEPAAX 12,427,1961


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value ceiling concentration 0.29 ppm;ceiling concentration 0.11 ppm (N3H vapor) DTLVS* TLV/BEI,2007
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value Not classifiable as human carcinogen DTLVS* TLV/BEI,2007
TOXICOLOGY REVIEW
FNSCA6 2,67,1973
TOXICOLOGY REVIEW
MUREAV 567,347,2004
TOXICOLOGY REVIEW
MUREAV 613,17,2006
TOXICOLOGY REVIEW
MUREAV 635,90,2007
TOXICOLOGY REVIEW
IJTOFN 22,175,2003
TOXICOLOGY REVIEW
ENTOX* -,60,2005
TOXICOLOGY REVIEW
MUREAV 658,28,2008


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

Occupational Exposure Limit - AUSTRALIA ceiling concentration 0.11 ppm (0.3 mg/m3), JUL2008
Occupational Exposure Limit - BELGIUM time-weighted average 0.1 mg/m3, short term exposure limit 0.3 mg/m3, Skin, MAR2002
Occupational Exposure Limit - DENMARK time-weighted average 0.1 mg/m3, OCT 2002
Occupational Exposure Limit - EC time-weighted average 0.1 mg/m3;
short term exposure limit 0.3 mg/m3 (skin), FEB 2006
Occupational Exposure Limit - FINLAND time-weighted average 0.1 ppm (0.3 mg/m3), short term exposure limit 0.3 ppm (0.9 mg/m3), JAN1999
Occupational Exposure Limit - FRANCE VME 0.1 mg/m3, VLE 0.3 mg/m3, Skin, FEB2006
Occupational Exposure Limit - GERMANY MAK 0.2 mg/m3 (inhalable), 2005
Occupational Exposure Limit - HUNGARY time-weighted average 0.1 mg/m3, short term exposure limit 0.3 mg/m3, SEP2000
Occupational Exposure Limit - KOREA ceiling concentration 0.1 ppm (0.3 mg/m3), 2006
Occupational Exposure Limit - THE NETHERLANDS MAC-TGG 0.1 mg/m3, Skin, 2003
Occupational Exposure Limit - NEW ZEALAND ceiling concentration 0.11 ppm (0.29 mg/m3), JAN2002
Occupational Exposure Limit - SWEDEN time-weighted average 0.1 mg/m3;
short term exposure limit 0.3 mg/m3, Skin, JUN2005
Occupational Exposure Limit - SWITZERLAND MAK- week 0.2 mg/m3,KZG- week 0.4e mg/m3, DEC2006
Occupational Exposure Limit - UNITED KINGDOM time-weighted average 0.1 mg/m3;
short term exposure limit 0.3 mg/m3 (skin), 2005
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value;

Not classifiable as human carcinogen
Occupational Exposure Limit IN SINGAPORE, VIETNAM American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
Not classifiable as human carcinogen


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO SODIUM AZIDE, as HN3-air ceiling concentration 0.1 ppm (Sk) NIOSH* DHHS #92-100,1992
National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 68820;
Number of Industries 13;
Total Number of Facilities 877;
Number of Occupations 10;
Total Number of Employees Exposed 5,953
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 68820;
Number of Industries 19;
Total Number of Facilities 3,640;
Number of Occupations 27;
Total Number of Employees Exposed 54,959;
Total Number of Female Employees Exposed 38,370


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test
EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation; S cerevisiae-reversion
EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-human lymphocyte
EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; In vitro UDS-human fibroblast
EPA GENETOX PROGRAM 1988, Negative: TRP reversion
EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat; TRP reversion
EPA TSCA Section 8(b) CHEMICAL INVENTORY
Used in preparation of LEAD AZIDE for explosives and as preservative and diluent
EPA TSCA Section 8(d) unpublished health/safety studies
On EPA IRIS database
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
NIOSH CURRENT INTELLIGENCE BULLETIN 13, 1976
NCI Carcinogenesis Studies (gavage);no evidence:rat
OSHA ANALYTICAL METHOD #ID211


REFERENCES:

CODEN
REFERENCE

AECTCV Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974-
ATXKA8 Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN.
BECTA6 Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947-
BJIMAG British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944-
BRAIAK Brain; Journal of Neurology. (Oxford Univ. Press, Walton St., Oxford OX2 6DP, UK) V.1- 1878-
CPBTAL Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958-
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
DCTODJ Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78-
DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987-
ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG.
ENTOX* Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945-
FCTOD7 Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982-
FMCHA2 Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094)
FNSCA6 Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR.
IJTOFN International Journal of Toxicology. (Taylor & Francis, 47 Runway Rd., Suite g, Levittown, PA 19057) V.16- 1997-
JATOD3 Journal of Analytical Toxicology. (Preston Pub. Inc., POB 48312, Niles, IL 60648) V.1- 1977-
JCPAAK Journal of Clinical Pathology. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1947-
JFSCAS Journal of Forensic Sciences. (American Soc. for Testing and Materials, 1916 Race St., Philadelphia, PA 19103) V.1- 1956-
JIHTAB Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU.
JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ.
JTCTDW Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982-
MEPAAX Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950-
MTAEEB Medical Toxicology and Adverse Drug Experience. (Adis International Ltd., Private Baq 65901, Mairangi Bay, Auckland 10, N.Z.) V.4- 1989-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986-
NIOSH* National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda.
NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information.
NTPTR* National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206-
PHRPA6 Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878-
POASAD Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920-
STBIBN Studia Biophysica. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.1- 1966-
STGNBT "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999
TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980-
TOXID9 Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981-
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
VCVN5* "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989.
VHTODE Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-

Used in preparation of LEAD AZIDE for explosives and as preservative and diluent

NIOSH PROFILE (AZIDES, INORGANIC), SRC, 10/81

NIOSH PROFILE (SODIUM AZIDE), SRI, 2/77

RTECS Compound Description:
   Agricultural Chemical
   Tumorigen
   Drug
   Mutagen
   Human Data

ALT CAS #: 12136-89-9
Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us